Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline

Journal of Affective Disorders

Volumn 132, Issue 1-2, 2011, Pages 112-120

  Uher, Rudolf ^a   Dernovsek, Mojca Zvezdana ^b   Mors, Ole ^c   Hauser, Joanna ^d   Souery, Daniel ^e   Zobel, Astrid ^f   Maier, Wolfgang ^f   Henigsberg, Neven ^g   Kalember, Petra ^g   Rietschel, Marcella ^h   Placentino, Anna ⁱ   Mendlewicz, Julien ^e   Aitchison, Katherine J ^a   McGuffin, Peter ^a   Farmer, Anne ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b University Psychiatric Clinic   (Slovenia)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f UNIVERSITY OF BONN   (Germany)

^g UNIVERSITY OF ZAGREB   (Croatia)

^h CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

ⁱ UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Anxious depression; Atypical depression; Depression; Melancholic depression; SSRI; Tricyclic antidepressants

Indexed keywords

ESCITALOPRAM; NORTRIPTYLINE;

ADULT; ARTICLE; ATYPICAL DEPRESSION; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; MIXED ANXIETY AND DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; CITALOPRAM; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTRIPTYLINE; PERSONALITY INVENTORY; PROGNOSIS; PSYCHOMETRICS; SOMATOFORM DISORDERS;

EID: 79958153835     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.02.014     Document Type: Article

References (49)

1. A.T. Beck, C.H. Ward, M. Mandelson, J. Mock, and J. Erbaugh An inventory for measuring depression Arch. Gen. Psychiatry. 4 1961 561 571
2. W.A. Brown Treatment response in melancholia Acta Psychiatr. Scand. Suppl. 2007 125 129 (Pubitemid 46114847)
3. P.J. Clayton, W.M. Grove, W. Coryell, M. Keller, R. Hirschfeld, and J. Fawcett Follow-up and family study of anxious depression Am. J. Psychiatry. 148 1991 1512 1517
4. M. Fava, L.A. Uebelacker, J.E. Alpert, A.A. Nierenberg, J.A. Pava, and J.F. Rosenbaum Major depressive subtypes and treatment response Biol. Psychiatry. 42 1997 568 576 (Pubitemid 27425475)
5. M. Fava, J.F. Rosenbaum, S.L. Hoog, R.G. Tepner, J.B. Kopp, and M.E. Nilsson Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression J. Affect. Disord. 59 2000 119 126 (Pubitemid 30317428)
6. M. Fava, A.J. Rush, J.E. Alpert, G.K. Balasubramani, S.R. Wisniewski, C.N. Carmin, M.M. Biggs, S. Zisook, A. Leuchter, R. Howland, D. Warden, and M.H. Trivedi Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report Am. J. Psychiatry. 165 2008 342 351 (Pubitemid 351704490)
7. M. Hamilton Development of a rating scale for primary depressive illness Brit. J. Clin. Psychol. 6 1967 278 296
8. R.T. Joffe, R.M. Bagby, and A. Levitt Anxious and nonanxious depression Am. J. Psychiatry. 150 1993 1257 1258 (Pubitemid 23218913)
9. U. Jonsson, H. Bohman, L. von Knorring, G. Olsson, A. Paaren, and A.-L. von Knorring Mental health outcome of long-term and episodic adolescent depression: 15-year follow-up of a community sample J. Affect. Disord. 130 2011 395 404
10. P.R. Joyce, R.T. Mulder, S.E. Luty, J.M. McKenzie, and A.M. Rae A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender Acta Psychiatr. Scand. 108 2003 20 23 (Pubitemid 36783277)
11. P.R. Joyce, R.T. Mulder, J.M. McKenzie, S.E. Luty, and C.R. Cloninger Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline Depress. Anxiety 19 2004 180 186 (Pubitemid 38685535)
12. A. Korszun, V. Moskvina, S. Brewster, N. Craddock, F. Ferrero, M. Gill, I.R. Jones, L.A. Jones, W. Maier, O. Mors, M.J. Owen, M. Preisig, T. Reich, M. Rietschel, A. Farmer, and P. McGuffin Familiality of symptom dimensions in depression Arch. Gen. Psychiatry. 61 2004 468 474 (Pubitemid 38620845)
13. B. Lafer, A.A. Nierenberg, J.F. Rosenbaum, and M. Fava Outpatients with DSM-III-R versus DSM-IV melancholic depression Compr. Psychiatry. 37 1996 37 39 (Pubitemid 26024875)
14. A.F. Leuchter, I.A. Cook, W.S. Gilmer, L.B. Marangell, K.S. Burgoyne, R.H. Howland, M.H. Trivedi, S. Zisook, R. Jain, M. Fava, D. Iosifescu, and S. Greenwald Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder Psychiatry Res. 169 2009 132 138
15. M.R. Liebowitz, F.M. Quitkin, J.W. Stewart, P.J. McGrath, W.M. Harrison, J.S. Markowitz, J.G. Rabkin, E. Tricamo, D.M. Goetz, and D.F. Klein Antidepressant specificity in atypical depression Arch. Gen. Psychiatry. 45 1988 129 137 (Pubitemid 18052843)
16. P.J. McGrath, J.W. Stewart, M.N. Janal, E. Petkova, F.M. Quitkin, and D.F. Klein A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression Am. J. Psychiatry. 157 2000 344 350 (Pubitemid 30145918)
17. P.J. McGrath, A.Y. Khan, M.H. Trivedi, J.W. Stewart, D.W. Morris, S.R. Wisniewski, S. Miyahara, A.A. Nierenberg, M. Fava, and J.A. Rush Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report J. Clin. Psychiatry. 69 2008 1847 1855
18. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br. J. Psychiatry. 134 1979 382 389 (Pubitemid 9136500)
19. J.C. Nelson Anxious depression and response to treatment Am. J. Psychiatry. 165 2008 297 299 (Pubitemid 351704479)
20. J.C. Nelson Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials Depress. Anxiety 27 2010 12 18
21. J.C. Nelson, K. Delucchi, and L.S. Schneider Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis Int. J. Geriatr. Psychiatry. 24 2009 539 544
22. G. Parker, K. Wilhelm, P. Mitchell, K. Roy, and D. Hadzi-Pavlovic Subtyping depression: testing algorithms and identification of a tiered model J. Nerv. Ment. Dis. 187 1999 610 617 (Pubitemid 29489504)
23. G. Parker, K. Fletcher, M. Hyett, D. Hadzi-Pavlovic, M. Barrett, and H. Synnott Measuring melancholia: the utility of a prototypic symptom approach Psychol. Med. 39 2009 989 998
24. G. Parker, M. Fink, E. Shorter, M.A. Taylor, H. Akiskal, G. Berrios, T. Bolwig, W.A. Brown, B. Carroll, D. Healy, D.F. Klein, A. Koukopoulos, R. Michels, J. Paris, R.T. Rubin, R. Spitzer, and C. Swartz Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am. J. Psychiatry. 167 2010 745 747
25. E.S. Paykel, P.R. Rowan, R.R. Parker, and A.V. Bhat Response to phenelzine and amitriptyline in subtypes of outpatient depression Arch. Gen. Psychiatry. 39 1982 1041 1049 (Pubitemid 12020987)
26. P.J. Perry Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants J. Affect. Disord. 39 1996 1 6 (Pubitemid 26235318)
27. E.D. Peselow, M.P. Sanfilipo, C. Difiglia, and R.R. Fieve Melancholic/endogenous depression and response to somatic treatment and placebo Am. J. Psychiatry. 149 1992 1324 1334
28. F.W. Reimherr, D.R. Wood, B. Byerley, J. Brainard, and B.I. Grosser Characteristics of responders to fluoxetine Psychopharmacol. Bull. 20 1984 70 72 (Pubitemid 14128872)
29. A.J. Rush, and J.E. Weissenburger Melancholic symptom features and DSM-IV Am. J. Psychiatry. 151 1994 489 498 (Pubitemid 24115811)
30. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, D. Warden, G. Niederehe, M.E. Thase, P.W. Lavori, B.D. Lebowitz, P.J. McGrath, J.F. Rosenbaum, H.A. Sackeim, D.J. Kupfer, J. Luther, and M. Fava Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am. J. Psychiatry. 163 2006 1905 1917 (Pubitemid 44807782)
31. A.J. Rush, S.R. Wisniewski, D. Warden, J.F. Luther, L.L. Davis, M. Fava, A.A. Nierenberg, and M.H. Trivedi Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features Arch. Gen. Psychiatry. 65 2008 870 880
32. J.M. Russell, L.M. Koran, J. Rush, R.M. Hirschfeld, W. Harrison, E.S. Friedman, S. Davis, and M. Keller Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression Depress. Anxiety 13 2001 18 27 (Pubitemid 32537090)
33. G.E. Simon, and R.H. Perlis Personalized medicine for depression: can we match patients with treatments? Am. J. Psychiatry. 167 2010 1445 1455
34. J.W. Stewart, P.J. McGrath, J.G. Rabkin, and F.M. Quitkin Atypical depression: a valid clinical entity? Psychiatr. Clin. North Am. 16 1993 479 495 (Pubitemid 23274042)
35. J.W. Stewart, P.J. McGrath, and F.M. Quitkin Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features? Neuropsychopharmacology 26 2002 237 245 (Pubitemid 34093086)
36. J.W. Stewart, P.J. McGrath, F.M. Quitkin, and D.F. Klein DSM-IV depression with atypical features: is it valid? Neuropsychopharmacology 34 2009 2625 2632
37. J.W. Stewart, P.J. McGrath, M. Fava, S.R. Wisniewski, S. Zisook, I. Cook, A.A. Nierenberg, M.H. Trivedi, G.K. Balasubramani, D. Warden, I. Lesser, and R.A. John Do atypical features affect outcome in depressed outpatients treated with citalopram? Int. J. Neuropsychopharmacol. 13 2010 15 30
38. M.E. Thase Atypical depression: useful concept, but it's time to revise the DSM-IV criteria Neuropsychopharmacology 34 2009 2633 2641
39. G.D. Tollefson, S.L. Holman, M.E. Sayler, and J.H. Potvin Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features J. Clin. Psychiatry. 55 1994 50 59 (Pubitemid 24081821)
40. R. Uher The implications of gene-environment interactions in depression: will cause inform cure? Mol. Psychiatry. 13 2008 1070 1078
41. R. Uher, A. Farmer, W. Maier, M. Rietschel, J. Hauser, A. Marusic, O. Mors, A. Elkin, R.J. Williamson, C. Schmael, N. Henigsberg, J. Perez, J. Mendlewicz, J.G. Janzing, A. Zobel, M. Skibinska, D. Kozel, A.S. Stamp, M. Bajs, A. Placentino, M. Barreto, P. McGuffin, and K.J. Aitchison Measuring depression: comparison and integration of three scales in the GENDEP study Psychol. Med. 38 2008 289 300 (Pubitemid 351156595)
42. R. Uher, W. Maier, J. Hauser, A. Marusic, C. Schmael, O. Mors, N. Henigsberg, D. Souery, A. Placentino, M. Rietschel, A. Zobel, M. Dmitrzak-Weglarz, A. Petrovic, L. Jorgensen, P. Kalember, C. Giovannini, M. Barreto, A. Elkin, S. Landau, A. Farmer, K.J. Aitchison, and P. McGuffin Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression Br. J. Psychiatry. 194 2009 252 259
43. R. Uher, O. Mors, J. Hauser, M. Rietschel, W. Maier, D. Kozel, N. Henigsberg, D. Souery, A. Placentino, N. Perroud, M.Z. Dernovsek, J. Strohmaier, E.R. Larsen, A. Zobel, A. Leszczynska-Rodziewicz, P. Kalember, L. Pedrini, S. Linotte, C. Gunasinghe, K.J. Aitchison, P. McGuffin, and A. Farmer Body weight as a predictor of antidepressant efficacy in the GENDEP project J. Affect. Disord. 118 2009 147 154
44. R. Uher, B. Muthen, D. Souery, O. Mors, J. Jaracz, A. Placentino, A. Petrovic, A. Zobel, N. Henigsberg, M. Rietschel, K.J. Aitchison, A. Farmer, and P. McGuffin Trajectories of change in depression severity during treatment with antidepressants Psychol. Med. 40 2010 1367 1377
45. R. Uher, N. Perroud, M.Y. Ng, J. Hauser, N. Henigsberg, W. Maier, O. Mors, A. Placentino, M. Rietschel, D. Souery, T. Zagar, P.M. Czerski, B. Jerman, E.R. Larsen, T.G. Schulze, A. Zobel, S. Cohen-Woods, K. Pirlo, A.W. Butler, P. Muglia, M.R. Barnes, M. Lathrop, A. Farmer, G. Breen, K.J. Aitchison, I. Craig, C.M. Lewis, and P. McGuffin Genome-wide pharmacogenetics of antidepressant response in the GENDEP project Am. J. Psychiatry. 167 2010 555 564
46. Uher, R.; Mors, O.; Rietschel, M.; Rajewska-Rager, A.; Petrovic, A.; Zobel, A.; Henigsberg, N.; Mendlewicz, J.; Aitchison, K.J.; Farmer, A.; McGuffin, P.; in press-a. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression. J. Clin. Psychiatry.
47. Uher, R.; Caspi, A.; Houts, R.; Sugden, K.;Williams, B.; Poulton, R.; Moffitt, T.E.; in press-b. Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: Replications and implications for resolving inconsistent results. J. Affect. Disord.
48. E.D. West, and P.J. Dally Effects of ipronizid in depressive syndromes Br. Med. J. 1 1959 1491 1494
49. J.K. Wing, N. Sartorius, and T.B. Ustin Diagnosis and clinical measurement in psychiatry A reference manual for SCAN 1998 World Health Organization Geneva